Acrivon Therapeutics (ACRV) Insider Trading & Ownership → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free ACRV Stock Alerts $9.50 -0.32 (-3.26%) (As of 04/24/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Acrivon Therapeutics (NASDAQ:ACRV) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.30%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$20.00 MNumber OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$35,718.97 Get ACRV Insider Trade Alerts Want to know when executives and insiders are buying or selling Acrivon Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ACRV Insider Buying and Selling by Quarter Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him Acrivon Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/11/2024Perceptive Advisors LlcMajor ShareholderBuy2,353,000$8.50$20,000,500.00 6/26/2023Ltd ChioneMajor ShareholderSell16$12.93$206.88 6/14/2023Ltd ChioneMajor ShareholderSell893$12.13$10,832.09 6/12/2023Ltd ChioneMajor ShareholderSell2,000$12.34$24,680.00 (Data available from 1/1/2013 forward) ACRV Insider Trading Activity - Frequently Asked Questions Who is on Acrivon Therapeutics's Insider Roster? The list of insiders at Acrivon Therapeutics includes Ltd Chione, Perceptive Advisors Llc, and Ra Capital Management, L.P.. Learn more on insiders at ACRV. What percentage of Acrivon Therapeutics stock is owned by insiders? 7.30% of Acrivon Therapeutics stock is owned by insiders. Learn more on ACRV's insider holdings. Which Acrivon Therapeutics insiders have been buying company stock? The following insiders have purchased ACRV shares in the last 24 months: Ltd Chione ($5,000,000.00), Perceptive Advisors Llc ($20,000,500.00), and Ra Capital Management, L.P. ($42,368,750.00). How much insider buying is happening at Acrivon Therapeutics? Insiders have purchased a total of 6,142,500 ACRV shares in the last 24 months for a total of $67,369,250.00 bought. Which Acrivon Therapeutics insiders have been selling company stock? The following insider sold ACRV shares in the last 24 months: Ltd Chione ($35,718.97). How much insider selling is happening at Acrivon Therapeutics? Insiders have sold a total of 2,909 Acrivon Therapeutics shares in the last 24 months for a total of $35,718.97 sold. More Insider Trading Tools from MarketBeat Related Companies: MACK Insider Ownership THRX Insider Ownership SYRS Insider Ownership NGM Insider Ownership VTGN Insider Ownership KNTE Insider Ownership ASMB Insider Ownership VTVT Insider Ownership SLDB Insider Ownership AVRO Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:ACRV) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acrivon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
